Diagnostics
Innovation
Biotech
Environment
Testing
Research
Diagnostics
Innovation
Biotech
Diagnostics
Innovation
Biotech
Environment
Testing
Research
Diagnostics
Innovation
Biotech
Ariba & Mac Limited is a Saudi joint venture between Ariba Health Care (USA) and Mac & Rains Group (Pakistan, UK, Turkey), bringing together 30+ years of global expertise in pharmaceuticals, biotechnology, and clinical research. We connect R&D organizations, clinical institutions, and pharmaceutical companies—delivering advanced research solutions, regulatory excellence, and technology-transfer services fully aligned with Saudi Vision 2030.
Ariba & Mac Limited is a Saudi Arabia-based life sciences and healthcare consultancy supporting pharmaceutical, biotechnology, healthcare, cosmetology and aesthetics projects. Our model connects research, regulatory strategy, CMC and manufacturing, facility development and technology transfer so clients can manage scientific, compliance and execution decisions as one coordinated program.
In the near future, Ariba & Mac Limited plans to establish a full-fledged International Research and Innovation Centre in Jeddah, Saudi Arabia, equipped with modern infrastructure for focused Cancer and Biotechnology Research, Development, and Technology Transfer. Our goal is to enable local commercial organizations to access high-quality R&D in the shortest possible time and at the lowest feasible cost, aligned with the broader objectives of Vision 2030.
We help sponsors, manufacturers, healthcare investors and research organizations move from concept to execution through pharmaceutical R&D, regulatory planning, CMC/manufacturing oversight, quality systems and commercialization support. The goal is to identify technical and regulatory risks early, define practical deliverables and maintain documentation that can support the next development, investment or market milestone.
Our lab delivers data-driven insights that help protect nature.
Formulation development, Analytical development, Validations for Pharmaceuticals, Biopharmaceuticals, Nutraceuticals & Cosmetics.
IND, IMPD, NDA, BLA, MAA, Medical devices, eCTD and DMF; FDA/EMA/SFDA/MENA/MHRA/GCC/DRAP.
CMO/CDMO/CRO selection & oversight, process design and scale-up to GMP commercial.
Value communication, payer strategy, launch planning and execution.
Our teams work across FDA, EMA, SFDA, MHRA, GCC/GHC and DRAP-oriented requirements while keeping Saudi project realities in view. We connect regulatory planning with R&D, CMC, quality and facility workstreams to reduce avoidable rework and maintain a clear evidence trail from development through launch readiness.
End-to-end guidance across IND, IMPD, NDA, BLA, MAA, Medical devices, eCTD and DMF.
From CMO/CDMO/CRO selection to GMP launch with measurable milestones.
We've compiled answers to the most common questions about our lab services, research process, and capabilities.
We provide formulation, validation, analytical & microbiology testing, CTD/DMF support and technology transfer services.
Yes. We scope custom R&D programs with defined deliverables, timelines and regulatory pathways.
Timelines depend on dosage form and regulatory needs. We provide a project plan with milestones after the initial consultation.
Project execution may involve Ariba & Mac teams and external laboratory or technology partners. Certifications or accreditations depend on the specific facility used for the project, and relevant credentials should be confirmed during project scoping.
Use the contact form to outline your needs. We will schedule an advisory call and share a document checklist.